Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

To investigate efficacy and safety of pemetrexed combined with cisplatin for chemo-naive patients with Malignant Pleural Mesothelioma.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Cisplatin; Pemetrexed

Criteria

Inclusion Criteria:

• Inapplicable for radical operation

• Not received prior systemic chemotherapy

• Performance status: 0-1

Exclusion Criteria:

• Having a history of sensitivity to platinum agent, folic acid or vitamin B12